Research Library | Baker Institute

Center for Health and Biosciences | U.S. Health System Transformation | Journal

Financial Impacts and Operational Implications of Private Equity Acquisition of U.S. Hospitals

A study of U.S. hospitals acquired by private equity firms found improved financial performance — and that patient throughput (or the process of admitting, treating and discharging patients) increased while staffing decreased.

Vivian Ho, Anaeze C. Offodile II May 2, 2022

Center for Health and Biosciences | Journal

Comparing the Ratio of Therapist Support to Internet Sessions in a Blended Therapy Delivered to Trauma-Exposed Veterans

Meta-analyses and reviews have found that trauma-exposed individuals receive moderate benefits for posttraumatic stress…

Jan Lindsay April 27, 2022

Center for Health and Biosciences | Journal

Current Approaches in Telehealth and Telerehabilitation for Spinal Cord Injury

Living with a spinal cord injury (SCI) is challenging and complex, requiring significant support and effort from the…

Jan Lindsay April 26, 2022

Center for Health and Biosciences | Journal

Unproven Stem Cell-based Interventions and Harm to Existing and Future Patients

Companies developing stem cell-based interventions should work with policymakers and patient advocates to address risks for current and future patients and to protect clinical research and the reputation of the field, write the authors. Read their full article in Cell & Gene Therapy Insights (free registration).

Kirstin R.W. Matthews, Flora Naylor April 4, 2022

Science and Technology Policy | Journal

Let’s Not Abandon Russian Scientists

In a joint letter, a group of scientists calls on U.S. policymakers and the nation's scientific communities to avoid shunning Russian scientists and academics for the actions of Russia's government in light of the invasion of Ukraine.

Neal F. Lane March 24, 2022

Center for Health and Biosciences | Science and Technology Policy | Journal

Role of Physicians in Guiding Patients Away From Unproven Stem Cell Interventions

The intense marketing of unproven stem cell interventions has become an international health concern. The authors offer resources and suggestions for physicians seeking to effectively counsel patients and respond to their questions about various stem cell therapies.

Kirstin R.W. Matthews, Zubin Master March 21, 2022

Center for Health and Biosciences | Journal

Association of Level I and II Trauma Center Expansion With Insurer Payments in Texas From 2011 to 2019

Analyzing insurance claims for BlueCross BlueShield of Texas, the authors found that level I and II trauma center expansion was not associated with increased prices or use of trauma activation fees in the state of Texas. Read the article in JAMA.

Vivian Ho, Marah Short March 17, 2022

U.S. Health System Transformation | Center for Health and Biosciences | Newsletter

Did Recent Efforts to Develop Policy for Genome Editing Have Adequate Public Engagement?

Input from the public is particularly important when developing science policies that involve controversial and morally complex issues, the authors write.

Kirstin R.W. Matthews, Ana S. Iltis March 10, 2022

Center for Health and Biosciences | Journal

The Impact of Operational Partnership on Telemental Health Before, During, and After COVID-19

The coronavirus disease (COVID-19) pandemic significantly accelerated the growth of telehealth services within the Veterans…

Jan Lindsay February 24, 2022

Center for Energy Studies | Journal

On the Reduced Supply Chain Risks and Mining Involved in the Transition From Coal to Wind

The authors respond to a critique of their prior article, elaborating on how "a switch from fossil fuel systems to renewables involves sharp declines in risk and mining."

Jim Krane February 18, 2022